Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Biovirtus Soluções Ambientais Ltda holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. The company currently has 1 pending office action. This matter is being examined within 1 distinct art unit, reflecting a focused technical review. Prosecution is managed by a distinct examiner, which concentrates the company's current legal efforts on a single point of contact within the patent office.
The busiest examiner is ARIANI, KADE, who is overseeing 1 pending office action, representing the entirety of the company's active pending matters. With only 1 distinct examiner and 1 distinct art unit involved, the prosecution for this Biotechnology & Pharmaceuticals portfolio is highly streamlined. This 1 pending office action is the sole focus of the company's current administrative activity. For Biovirtus Soluções Ambientais Ltda, the reliance on a single examiner for its 1 pending office action indicates a very specific prosecution strategy.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ARIANI, KADE | 1 | 75.0% | +32.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18846785 | LIQUID PROBIOTIC COMPOSITION FOR GREATER TOLERANCE TO HEAT STRESS IN POULTRY, METHOD OF PRODUCING THE COMPOSITION AND USE THEREOF IN THE TREATMENT OF POULTRY | ARIANI, KADE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18846785 | LIQUID PROBIOTIC COMPOSITION FOR GREATER TOLERANCE TO HEAT STRESS IN POULTRY, METHOD OF PRODUCING THE COMPOSITION AND USE THEREOF IN THE TREATMENT OF POULTRY | ARIANI, KADE | — |
| Art Unit | Apps |
|---|---|
| 1651 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18846785 | LIQUID PROBIOTIC COMPOSITION FOR GREATER TOLERANCE TO HEAT STRESS IN POULTRY, METHOD OF PRODUCING THE COMPOSITION AND USE THEREOF IN THE TREATMENT OF POULTRY | ARIANI, KADE | 1651 | §101§103§112 | Non-Final OA | — | Pending | Sep 13, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBiovirtus Soluções Ambientais Ltda has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kade Ariani has the most, with 1 of Biovirtus Soluções Ambientais Ltda's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
